Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1165P is a genomic locus annotated as a **pseudogene** of the U6 small nuclear RNA gene in the human genome. U6 small nuclear RNA (snRNA) itself is a highly conserved, functional non-coding RNA crucial for the splicing of precursor mRNA in eukaryotes[3][1]. However, **RNU6-1165P does not produce a functional transcript** and does not participate in the spliceosome or any known cellular process[2][5]. Like many other U6 pseudogenes, it likely arose through gene duplication or retrotransposition events and may retain sequence similarity to the active U6 snRNA but lacks promoter elements or necessary structure for biological function[5][3]. There is no evidence that RNU6-1165P serves as a regulatory RNA, disease marker, or druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1165, pseudogene (RNU6-1165P).